Duloxetine HCL DR 20 MG cap 1000S
Ended Awarded Last action
- Contract number
- SPE2DR26F7MHL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,125
Award facts
- Contract value 100% obligated
- $1,125.25 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 25, 2025, for the supply of Duloxetine HCL (delayed-release) 20 mg capsules in a quantity of 1,000 units, valued at $1,125.25 with firm fixed pricing. This delivery order represents a non-set-aside, competitively awarded contract with a completion date of November 26, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The order falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a maximum value of $999,999,999.00 through December 2026, serving as the primary pharmaceutical supply vehicle for federal military healthcare requirements.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Pennsylvania, serves as a critical vendor for federal medical procurement across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive portfolio with DLA encompasses a comprehensive range of pharmaceutical products including brand-name and generic medications, specialty drugs, vaccines, and medical supplies across multiple therapeutic domains. This specific delivery order for Duloxetine HCL—a medication commonly used for neurological and pain management conditions—reflects the company's ongoing role in supporting military healthcare supply chain requirements through the DLA's flexible contracting mechanisms.
Quick answers
Who was awarded contract SPE2DR26F7MHL?
SPE2DR26F7MHL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 25, 2025.
How much is contract SPE2DR26F7MHL worth?
The government has obligated $1,125 on SPE2DR26F7MHL.
Is contract SPE2DR26F7MHL an order under another contract?
Yes. SPE2DR26F7MHL is a delivery order under SPE2DR25D7059, an indefinite delivery contract.
Was contract SPE2DR26F7MHL competed?
The extent of competition for SPE2DR26F7MHL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award